Report for: Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy

Title	Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy
Published in	PLOS ONE, November 2012
DOI	10.1371/journal.pone.0049279
Pubmed ID	23166628
Authors	Javier Ampuero, Isidora Ranchal, David Nuñez, María del Mar Díaz-Herrero, Marta Maraver, José Antonio del Campo, Ángela Rojas, Inés Camacho, Blanca Figueruela, Juan D. Bautista, Manuel Romero-Gómez
Abstract	To investigate the influence of metformin use on liver dysfunction and hepatic encephalopathy in a retrospective cohort of diabetic cirrhotic patients. To analyze the impact of metformin on glutaminase activity and ammonia production in vitro.

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Sweden	1	50%
Unknown	1	50%

Type	Count	As %
Members of the public	1	50%
Practitioners (doctors, other healthcare professionals)	1	50%

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Researcher	12	21%
Student > Bachelor	6	11%
Student > Postgraduate	5	9%
Other	4	7%
Student > Ph. D. Student	4	7%
Other	14	25%
Unknown	11	20%

Readers by discipline	Count	As %
Medicine and Dentistry	17	30%
Agricultural and Biological Sciences	11	20%
Biochemistry, Genetics and Molecular Biology	5	9%
Neuroscience	2	4%
Immunology and Microbiology	2	4%
Other	5	9%
Unknown	14	25%

PLOS